Exane Derivatives’s MannKind Corp MNKD Stock Holding History

Exane Derivatives’s Portfolio MNKD Stock Details MNKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8	Closed	-$21	–	856
2020 Q3	$15	Hold	8	–	–	﹤0.01%	748
2020 Q2	$14	Hold	8	–	–	﹤0.01%	683
2020 Q1	$8	Hold	8	–	–	﹤0.01%	698
2019 Q4	$12	Hold	8	–	–	﹤0.01%	676
2019 Q3	$10	Hold	8	–	–	﹤0.01%	651
2019 Q2	$9	Hold	8	–	–	﹤0.01%	661
2019 Q1	$16	Hold	8	–	–	﹤0.01%	619
2018 Q4	$8	Hold	8	–	–	﹤0.01%	666
2018 Q3	$15	Hold	8	–	–	﹤0.01%	682
2018 Q2	$15	Hold	8	–	–	﹤0.01%	673
2018 Q1	$20	Hold	8	–	–	﹤0.01%	607
2017 Q4	$19	Hold	8	–	–	﹤0.01%	595
2017 Q3	$17	Hold	8	–	–	﹤0.01%	560
2017 Q2	$11	Hold	8	–	–	﹤0.01%	623
2017 Q1	$12	Hold	8	–	–	﹤0.01%	557
2016 Q4	$25	Hold	8	–	–	﹤0.01%	606
2016 Q3	$25	Hold	8	–	–	﹤0.01%	593
2016 Q2	$46	Hold	8	–	–	﹤0.01%	498
2016 Q1	$64	Hold	8	–	–	﹤0.01%	543
2015 Q4	$58	Hold	8	–	–	﹤0.01%	465
2015 Q3	$128	Hold	8	–	–	﹤0.01%	481
2015 Q2	$228	Hold	8	–	–	﹤0.01%	471
2015 Q1	$208	Sell	8 -3,313	-100%	-$99.8K	﹤0.01%	474
2014 Q4	$86.6K	Buy	+3,321	New	+$93.8K	0.01%	296

Other funds holding MNKD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Exane Derivatives's MNKD Position: Q4 2020 in Review

Exane Derivatives sold out of MannKind Corp (MNKD) in Q4 2020, closing a stake of 8 shares — an estimated $21 sold.

Exane Derivatives first reported a position in MNKD in Q4 2014 and held it in 24 quarters. The position peaked at $86.6K in Q4 2014. 152 funds tracked by Wall St. Rank hold MNKD as of Q4 2020.

Exane Derivatives reported no remaining MannKind Corp position as of Q4 2020 after selling out during the quarter.
Exane Derivatives sold 8 MannKind Corp shares in Q4 2020, an estimated $21.
Exane Derivatives first reported a position in MannKind Corp in Q4 2014 and held it in 24 quarters.
Exane Derivatives's MannKind Corp position peaked at $86.6K in Q4 2014.
152 funds tracked by Wall St. Rank held MannKind Corp as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.